Anxiety and Related Sleep Disorders - Canada

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$259.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.38%, resulting in a market volume of US$264.30m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$120.70 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Canada has been experiencing significant growth in recent years.

Customer preferences: Customers in Canada are increasingly seeking solutions for anxiety and related sleep disorders. This can be attributed to several factors, including a growing awareness and understanding of mental health issues, as well as a shift in societal attitudes towards seeking help for these conditions. Additionally, the high-stress modern lifestyle, coupled with the prevalence of technology and social media, has contributed to an increase in anxiety and sleep disorders among the population. As a result, there is a rising demand for products and services that address these issues.

Trends in the market: One trend in the Anxiety and Related Sleep Disorders market in Canada is the increasing popularity of natural and holistic remedies. Many customers are turning to alternative therapies such as herbal supplements, meditation, and yoga to manage their anxiety and improve sleep quality. This trend is driven by a desire for natural solutions that have fewer side effects compared to traditional pharmaceutical options. As a result, there has been a surge in the availability and variety of natural products in the market.Another trend is the integration of technology into anxiety and sleep disorder management. The development of mobile applications and wearable devices has provided individuals with tools to track and manage their symptoms. These technologies offer features such as guided meditation, sleep tracking, and stress management techniques. The convenience and accessibility of these digital solutions have made them increasingly popular among consumers.

Local special circumstances: Canada has a universal healthcare system, which means that individuals have access to medical services without financial barriers. This has facilitated the diagnosis and treatment of anxiety and related sleep disorders, as individuals can seek professional help without worrying about the cost. The availability of healthcare professionals and specialized clinics dedicated to mental health has also contributed to the growth of the market.

Underlying macroeconomic factors: The strong Canadian economy has played a role in the growth of the Anxiety and Related Sleep Disorders market. With a stable job market and increasing disposable income, individuals have more resources to invest in their well-being. This has led to a willingness to spend on products and services that address anxiety and sleep disorders.In conclusion, the Anxiety and Related Sleep Disorders market in Canada is experiencing significant growth due to customer preferences for natural remedies and the integration of technology into treatment options. The country's universal healthcare system and strong economy have also contributed to the market's expansion. As awareness and understanding of mental health continue to increase, it is expected that the market will continue to grow in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.